XAIR

Beyond Air, Inc. · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website beyondair.net
Employees(FY) 98
ISIN US08862L1035

Performance

-17.26%

-23.16%

+5.5%

-68.01%

-79.43%

YTD

-78.9%

Profile

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

Advanced Technical Analysis

Technical Analysis of XAIR 2024-12-20

The stock indicators reflect a predominantly bearish sentiment, with the Moving Average Score at 3 and the Technical Score at 21, both indicating weak performance. The Oscillators Score of 40 suggests a neutral stance, but overall, the combined scores point to a lack of bullish momentum in the market.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of XAIR

Stock Rank

Recent News & Updates

2024-12-03 03:05
Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy(Globenewswire)
2024-12-01 18:30
Beyond Air Receives CE Mark in Europe for the LungFit PH System(Globenewswire)
2024-11-25 18:30
NeuroNOS Appoints Nobel Laureate, Roger D. Kornberg, to Scientific Advisory Board(Globenewswire)
2024-11-14 03:05
Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference(Globenewswire)
2024-11-11 03:05
Beyond Air Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update(Globenewswire)
2024-11-10 18:00
Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting(Globenewswire)
2024-11-07 18:06
Beyond Air Inc (XAIR) Q2 2025 Earnings Report Preview: What To Expect(Yahoo Finance)
2024-10-29 04:22
Beyond Air Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and Webcast(Globenewswire)
2024-10-06 19:00
Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting(Globenewswire)
2024-10-01 19:30
Beyond Air Partners with Healthcare Links to Expand Access to LungFit PH System Through Group Purchasing Organizations and Integrated Delivery Networks(Globenewswire)
2024-09-27 19:40
Beyond Air to sell 40.39M shares at 51c in private placement(Yahoo Finance)
2024-09-27 19:35
Beyond Air terminates loan, security agreements with Avenue Capital(Yahoo Finance)
2024-09-26 19:34
Beyond Air Provides LungFit PH System to U.S. Naval Hospital Guam for Neonatal Critical Care in Partnership with TrillaMed(Globenewswire)
2024-09-26 19:32
Beyond Air Announces Termination of the Loan and Security Agreements with Avenue Capital(Globenewswire)
2024-09-26 19:30
Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules(Globenewswire)
2024-09-22 20:00
Beyond Air to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference(Globenewswire)
2024-08-06 04:05
Beyond Air® Reports Fiscal First Quarter 2025 Financial Results and Provides Corporate Update(Yahoo Finance)
2024-07-31 04:15
Beyond Air Publishes Peer-Reviewed Journal Article in Scientific Reports with Clinical Data Showing Nitric Oxide was Safe and Beneficial Adjunct Therapy for Subjects with Viral Pneumonia(Globenewswire)
2024-07-23 04:05
Beyond Air to Report First Fiscal Quarter 2025 Financial Results on August 6(Globenewswire)
2024-07-16 04:05
Beyond Air To Participate in the BTIG Virtual Biotechnology Conference 2024(Globenewswire)
2024-07-09 21:55
Beyond Air (XAIR) Could Find a Support Soon, Here's Why You Should Buy the Stock Now(Zacks)
2024-06-25 20:01
Beyond Air, Inc. (NASDAQ:XAIR) Q4 2024 Earnings Call Transcript(Insidermonkey)
2024-06-24 22:31
Jefferies Just Raised Its Price Target on Nvidia (NVDA) Stock(Investorplace)
2024-06-24 20:28
Why Is Beyond Air (XAIR) Stock Down 22% Today?(Investorplace)
2024-06-24 19:37
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday(Investorplace)
2024-06-24 08:53
XAIR Stock Earnings: Beyond Air Beats EPS, Misses Revenue for Q4 2024(Investorplace)
2024-06-24 05:25
Beyond Air, Inc. (XAIR) Reports Q4 Loss, Misses Revenue Estimates(Zacks)
2024-06-24 04:15
Beyond Air Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update(Globenewswire)
2024-06-13 04:05
Beyond Air Appoints David Webster as Chief Commercial Officer(Globenewswire)
2024-06-02 19:00
Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO)(Globenewswire)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.